{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:15:29Z","timestamp":1794345329263,"version":"4.9.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T00:00:00Z","timestamp":1323388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1208\/s12249-011-9725-8","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T20:34:47Z","timestamp":1323376487000},"page":"101-111","source":"Crossref","is-referenced-by-count":51,"title":["In Vitro Characterization of Chitosan Gels for Buccal Delivery of Celecoxib: Influence of a Penetration Enhancer"],"prefix":"10.1208","volume":"13","author":[{"given":"Yara Peluso","family":"Cid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius","family":"Pedrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria Pereira","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Bernadete Riemma","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,9]]},"reference":[{"key":"9725_CR1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J","volume":"31","author":"LS Simon","year":"1998","unstructured":"Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor. Arthritis Rheum. 1998;31:1591\u2013602.","journal-title":"Arthritis Rheum"},{"key":"9725_CR2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1349-7006.1999.tb00690.x","volume":"90","author":"G Nishimura","year":"1999","unstructured":"Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M. A selective cyclooxygenase-2 inhibitor suppress tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Jpn J Cancer Res. 1999;90:1152\u201362.","journal-title":"Jpn J Cancer Res"},{"key":"9725_CR3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00005537-200205000-00012","volume":"112","author":"Z Wang","year":"2002","unstructured":"Wang Z, Fluentes CF, Shapshay SM. Anti-angiogenic and chemopreventive activities in oral carcinoma cell. Laryngoscope. 2002;112:839\u201343.","journal-title":"Laryngoscope"},{"key":"9725_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3835(03)00272-6","volume":"198","author":"Z Wang","year":"2003","unstructured":"Wang Z, Polavaram R, Shapshay SM. Topical inhibition of oral carcinoma cell with polymer delivered celecoxib. Cancer Lett. 2003;198:53\u20138.","journal-title":"Cancer Lett"},{"key":"9725_CR5","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ejca.2005.04.016","volume":"41","author":"JA Crowelli","year":"2005","unstructured":"Crowelli JA. The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview. Eur J Cancer. 2005;41:1889\u2013910.","journal-title":"Eur J Cancer"},{"key":"9725_CR6","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1053\/j.gastro.2008.10.073","volume":"135","author":"SM Lippman","year":"2008","unstructured":"Lippman SM. The future of molecular-target cancer chemoprevention. Gastroenterology. 2008;135:1834\u201341.","journal-title":"Gastroenterology"},{"key":"9725_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cdp.2003.12.005","volume":"28","author":"M Kemal K\u0131smet","year":"2004","unstructured":"Kemal K\u0131smet M, Turan Akay M, Osman Abbasoglu, Ayg\u00fcn Ercan MD. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Canc Detect Prev. 2004;28:127\u201342.","journal-title":"Canc Detect Prev"},{"key":"9725_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.oraloncology.2005.01.003","volume":"41","author":"S Sood","year":"2006","unstructured":"Sood S, Shiff SJ. Selection of topically applied no-steroidal anti-inflammatory drugs for oral cancer chemoprevention. Oral Oncol. 2006;41:562\u20137.","journal-title":"Oral Oncol"},{"key":"9725_CR9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2006.01.003","volume":"59","author":"JB M\u00e9ric","year":"2006","unstructured":"M\u00e9ric JB, Rottey S. Cyclooxyxenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol. 2006;59:51\u201364.","journal-title":"Crit Rev Oncol Hematol"},{"key":"9725_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3181\/00379727-216-44179","volume":"216","author":"V Papadimitrakopoulou","year":"1997","unstructured":"Papadimitrakopoulou V, Hon WK. Retinoids in head and neck chemoprevention. Proc Soc Exp Biol Med. 1997;216:283\u201390.","journal-title":"Proc Soc Exp Biol Med"},{"key":"9725_CR11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ejmech.2005.03.001","volume":"40","author":"CA Ventura","year":"2005","unstructured":"Ventura CA, Giannone I, Paolino D, Pistar\u00e0 V, Corsaro A, Puglisi G. Preparation of celecoxib\u2013dimethyl-b-cyclodextrin inclusion complex: characterization and in vitro permeation study. Eur J Med Chem. 2005;40:624\u201331.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"9725_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2006.02.006","volume":"314","author":"CA Ventura","year":"2006","unstructured":"Ventura CA, Tommasini S, Falcone A, Giannone I, Paolino D, Sdrafkakis V, et al. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin. Int J Pharm. 2006;314(1):37\u201345.","journal-title":"Int J Pharm"},{"key":"9725_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(98)00044-3","volume":"55","author":"C Remu\u00f1\u00e1n-L\u00f3pez","year":"1998","unstructured":"Remu\u00f1\u00e1n-L\u00f3pez C, Portero A, Vila-Jato JL, Alonso MJ. Design and evaluation of chitosan\/ethylcellulose mucoadhesive bilayer devices for buccal drug delivery. J Contr Release. 1998;55:143\u201352.","journal-title":"J Contr Release"},{"key":"9725_CR14","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.addr.2005.07.003","volume":"57","author":"N Salamat-Miller","year":"2005","unstructured":"Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57:1666\u201391.","journal-title":"Adv Drug Deliv Rev"},{"key":"9725_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2003.10.028","volume":"21","author":"G Sandri","year":"2004","unstructured":"Sandri G, Rossi S, Ferrari F, Bomferoni MC. Assessment of chitosan derivates as buccal and vaginal penetration enhancers. Eur J Pharm Sci. 2004;21:351\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"9725_CR16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2005.09.026","volume":"110","author":"CK Obara","year":"2005","unstructured":"Obara CK, Ishihara M, Ozeki Y, Ishizuka T. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J Contr Release. 2005;110:79\u201389.","journal-title":"J Contr Release"},{"key":"9725_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0939-6411(02)00118-2","volume":"55","author":"L Martin","year":"2003","unstructured":"Martin L, Wilson CG, Koosh F. Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm. 2003;55:35\u201345.","journal-title":"Eur J Pharm Biopharm"},{"key":"9725_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(98)00027-1","volume":"166","author":"P He","year":"1998","unstructured":"He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998;166:75\u201388.","journal-title":"Int J Pharm"},{"key":"9725_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.01.024","volume":"105","author":"JA Nicolazzo","year":"2005","unstructured":"Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers: how do they really work? J Contr Release. 2005;105:1\u2013115.","journal-title":"J Contr Release"},{"key":"9725_CR20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jps.20240","volume":"94","author":"JA Nicolazzo","year":"2005","unstructured":"Nicolazzo JA, Reed BLJ. Enhanced buccal mucosal retention and reduced buccal permeability of estradiol in the presence of padimate O and Azone: a mechanistic study. Pharm Sci. 2005;94:873\u201382.","journal-title":"Pharm Sci"},{"key":"9725_CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2005.03.022","volume":"105","author":"JA Nicolazzo","year":"2005","unstructured":"Nicolazzo JA, Reed BL, Finnin BC. Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Contr Release. 2005;105:240\u20138.","journal-title":"J Contr Release"},{"key":"9725_CR22","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0142-9612(00)00134-4","volume":"21","author":"S Senel","year":"2000","unstructured":"Senel S, Kremer MJ, Kas S. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials. 2000;21:2067\u201371.","journal-title":"Biomaterials"},{"key":"9725_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-409X(01)00231-9","volume":"52","author":"M Thanou","year":"2001","unstructured":"Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivates. Adv Drug Deliv Rev. 2001;52:117\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"9725_CR24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1590\/S0100-40422009000500040","volume":"32","author":"TS Moreira","year":"2009","unstructured":"Moreira TS, Cid YP, Pierre MBR, Kummerle AE, Fraga CAM, Sousa VP. Extra\u00e7\u00e3o e purifica\u00e7\u00e3o de f\u00e1rmacos antiinflamat\u00f3rios n\u00e3o esteroidais ciclooxigenase-2 seletivos. Qu\u00edmica Nova. 2009;32:1324\u20138.","journal-title":"Qu\u00edmica Nova"},{"key":"9725_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1208\/s12249-010-9420-1","volume":"11","author":"TS Moreira","year":"2010","unstructured":"Moreira TS, Sousa VP, Pierre MBR. A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation. AAPS PharmSciTech. 2010;11:621\u20139.","journal-title":"AAPS PharmSciTech"},{"key":"9725_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1381-5148(00)00038-9","volume":"46","author":"MNV Ravi Kumar","year":"2000","unstructured":"Ravi Kumar MNV. A review of chitin and chitosan applications. React Funct Polym. 2000;46:1\u201327.","journal-title":"React Funct Polym"},{"key":"9725_CR27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.carbpol.2008.06.015","volume":"75","author":"HH Sokker","year":"2009","unstructured":"Sokker HH, Abdel Ghaffar AM, Gad YH. Synthesis and characterization of hydrogels based on grafted chitosan for the controlled drug release. Carbohyd Polym. 2009;75:222\u20139.","journal-title":"Carbohyd Polym"},{"key":"9725_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S1516-93322005000100008","volume":"41","author":"NM Corr\u00eaa","year":"2005","unstructured":"Corr\u00eaa NM, Camargo Jr FB, Ign\u00e1cio RF, Leonardi GR. Avalia\u00e7\u00e3o do comportamento reol\u00f3gico de diferentes g\u00e9is hidrof\u00edlicos. Rev Bras Cienc Farm. 2005;41:73\u20138.","journal-title":"Rev Bras Cienc Farm"},{"key":"9725_CR29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.farmac.2004.03.010","volume":"59","author":"C Anchisi","year":"2004","unstructured":"Anchisi C. Physical properties of chitosan dispersions in glycolic acid. Il farmaco. 2004;59:557\u201361.","journal-title":"Il farmaco"},{"key":"9725_CR30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2007.12.027","volume":"356","author":"L Perioli","year":"2008","unstructured":"Perioli L, Pagano C, Mazzitelli S. Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration. Int J Pharm. 2008;356:18\u201328.","journal-title":"Int J Pharm"},{"key":"9725_CR31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1745-4603.1970.tb00740.x","volume":"1","author":"BW Barry","year":"2007","unstructured":"Barry BW. Recent advanced in pharmaceutical rheology. J Texture Stud. 2007;1:405\u201330.","journal-title":"J Texture Stud"},{"key":"9725_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2009.02.013","volume":"136","author":"CH Lee","year":"2009","unstructured":"Lee CH, Moturi V, Lee Y. Thixotropic property in pharmaceutical formulations. J Contr Release. 2009;136:88\u201398.","journal-title":"J Contr Release"},{"key":"9725_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","volume":"56","author":"AC Williams","year":"2004","unstructured":"Williams AC, Barry BW. Permeation enhancers. Adv Drug Deliv Rev. 2004;56:603\u201318.","journal-title":"Adv Drug Deliv Rev"},{"key":"9725_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2004.05.002","volume":"98","author":"P Aksungur","year":"2004","unstructured":"Aksungur P, Sungur A, Unal S, Iskit AB, Squier CA, Senel S. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies. J Contr Release. 2004;98:269\u201379.","journal-title":"J Contr Release"},{"key":"9725_CR35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpb.2009.10.003","volume":"74","author":"S Rossi","year":"2010","unstructured":"Rossi S, Marciello M, Bonferoni MC, Ferrari F, Sandri G, Dacarro C, et al. Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis. Eur J Pharm Biopharm. 2010;74:248\u201354.","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"9725_CR36","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1002\/jps.22175","volume":"99","author":"LB Heemstra","year":"2010","unstructured":"Heemstra LB, Finnin BC, Nicolazzo JA. The buccal mucosa as an alternative route for the systemic delivery of risperidone. J Pharm Sci. 2010;99(11):4584\u201392.","journal-title":"J Pharm Sci"},{"key":"9725_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2005.03.017","volume":"297","author":"G Sandri","year":"2005","unstructured":"Sandri G, Rossi S, Bonferoni MC. Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. Int J Pharm. 2005;297:146\u201355.","journal-title":"Int J Pharm"},{"key":"9725_CR38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0928-0987(00)00065-8","volume":"10","author":"S Rossi","year":"2000","unstructured":"Rossi S, Ferrari F, Bonferoni MC, Caramella C. Characterization of chitosan hydrochloride\u2013mucin interaction by means of viscosimetric and turbidimetric measurements. Eur J Pharm Sci. 2000;10:251\u20137.","journal-title":"Eur J Pharm Sci"},{"key":"9725_CR39","first-page":"361","volume":"76","author":"MJ Kremer","year":"1997","unstructured":"Kremer MJ, Squier CA, Wertz PW. Absorption and release of topical triamcinolone in oral mucosa. J Dent Res. 1997;76:361.","journal-title":"J Dent Res"},{"key":"9725_CR40","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1023\/A:1015052520467","volume":"16","author":"CA Squier","year":"1999","unstructured":"Squier CA, Kremer MJ, Bruskin A, Rose A, Haley JD. Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro. Pharm Res. 1999;16:1557\u201363.","journal-title":"Pharm Res"},{"key":"9725_CR41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425240903338758","volume":"7","author":"N Hassan","year":"2010","unstructured":"Hassan N, Ahad A, Ali M, Ali J. Chemical permeation enhancers for transbuccal drug delivery. Expet Opin Drug Deliv. 2010;7:97\u2013112.","journal-title":"Expet Opin Drug Deliv"},{"key":"9725_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0939-6411(00)00144-2","volume":"51","author":"F Veuillez","year":"2001","unstructured":"Veuillez F, Kalia YN, Jacques Y, Deshusses J, Buri P. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm. 2001;51:93\u2013109.","journal-title":"Eur J Pharm Biopharm"},{"key":"9725_CR43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archderm.1982.01650190028013","volume":"118","author":"RB Stoughton","year":"1982","unstructured":"Stoughton RB. Enhanced percutaneous absorption with 1-dodecylazacycloheptan-2-one (Azone). Arch Dermatol. 1982;118:474\u20137.","journal-title":"Arch Dermatol"},{"key":"9725_CR44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.2042-7158.1989.tb06405.x","volume":"41","author":"UT Lashmar","year":"1989","unstructured":"Lashmar UT, Hadgraft J, Thomas N. Topical application of penetration enhancers to the skin of nude mice: a histopathological study. J Pharm Pharmacol. 1989;41:118\u201321.","journal-title":"J Pharm Pharmacol"},{"key":"9725_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-5173(03)00086-3","volume":"255","author":"J Fang","year":"2003","unstructured":"Fang J, Hwang T, Fang C, Chiu H. In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm. 2003;255:153\u201366.","journal-title":"Int J Pharm"},{"key":"9725_CR46","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jps.2600791004","volume":"79","author":"EJ Hoogdalem Van","year":"1990","unstructured":"Van Hoogdalem EJ, Vermeij-Kerrs C, De Boer AG, Breimer DD. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo. J Pharm Sci. 1990;79:866\u201370.","journal-title":"J Pharm Sci"},{"key":"9725_CR47","first-page":"109","volume":"6","author":"G Durand-Cavagna","year":"1989","unstructured":"Durand-Cavagna G, Duprat P, Molon-Noblot S, Delort P, Rozier A. Corneal endothelial changes with azone, a penetration enhancer. Lens Eye Toxic Res. 1989;6:109\u201317.","journal-title":"Lens Eye Toxic Res"},{"key":"9725_CR48","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1023\/A:1015820009255","volume":"9","author":"IM Ismail","year":"1992","unstructured":"Ismail IM, Chen C, Richman JB, Andersen JS, Tang-Liu DD. Comparison of azone and hexamethylene lauramide in toxicologic effects and penetration enhancement of cimetidine in rabbit eyes. Pharm Res. 1992;9:817\u201321.","journal-title":"Pharm Res"},{"issue":"3","key":"9725_CR49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/03639040500518708","volume":"32","author":"M L\u00f3pez-Cervantes","year":"2006","unstructured":"L\u00f3pez-Cervantes M, M\u00e1rquez-Mej\u00eda E, C\u00e1zares-Delgadillo J, Quintanar-Guerrero D, Ganem-Quintanar A, \u00c1ngeles-Anguiano E. Chemical enhancers for the absorption of substances through the skin: laurocapram and its derivatives. Drug Dev Ind Pharm. 2006;32(3):267\u201386.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"9725_CR50","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1208\/pt060222","volume":"6","author":"DK Parikh","year":"2005","unstructured":"Parikh DK, Ghosh TK. Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech. 2005;6(2):E114\u201349.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"9725_CR51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/13543770902989983","volume":"19","author":"A Ahad","year":"2009","unstructured":"Ahad A, Aqil M, Kohli K, Chaudhary H, Sultana Y, Mujeeb M, et al. Chemical penetration enhancers: a patent review. Expert Opin Ther Pat. 2009;19(7):969\u201388.","journal-title":"Expert Opin Ther Pat"},{"key":"9725_CR52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.colsurfb.2008.06.005","volume":"66","author":"L Perioli","year":"2008","unstructured":"Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B Biointerfaces. 2008;66:141\u20135.","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-011-9725-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-011-9725-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-011-9725-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:48:17Z","timestamp":1559620097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-011-9725-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,9]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9725"],"URL":"https:\/\/doi.org\/10.1208\/s12249-011-9725-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,9]]}}}